US$ 25.97
insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Size & Share Report, 2032 Glucagon Like Peptide-1 (GLP-1) Agonists
Description
GLP-1 medication may work faster or slower for each person, depending on their health and lifestyle, especially with weight loss

And its neuroprotective effect has become a research hotspot in recent years

Fraser JA, Bruce BB, Rucker J, Fraser LA, Atkins EJ, Newman NJ, Biousse V

These findings indicate that GLP-1RAs limit and stabilize the development of atherosclerotic plaques through anti-inflammatory mechanisms and by preventing vascular remodeling [62]

The cardiovascular biology of glucagon-like peptide-1
